Naturi Corporation was launched, founded in 2005 in order to produce a cholesterol-lowering drug of the by-products of rice bran oil. When operations are divided between Chennai, India and Boston, Massachusetts, Naturi faced several challenges, including the provision of funding for the organization. Naturi has captured the attention of at least four potential investors are ready to invest. Its leaders were challenged to weigh the possibilities and determine which of the four potential investors currently interested in their company will be the most suitable for future growth in the Naturi. In addition, the founders had only a short time to decide whether or not to seed the term sheet and a series of well-known venture capital firms. Raises the question of how to finance the company should be structured and how much capital the founders have to give in exchange for seed capital. "Hide
by Robert F. Higgins, Virginia A. Fuller Source: Harvard Business School 24 pages. Publication Date: January 29, 2007. Prod. #: 807027-PDF-ENG
Related Case Solutions & Analyses:
Euro Takeover 2005 (D) The White Knight: Alimentos Globales S.A.
HP Nanotech: Partnership with CNSI
Capital Market Myopia
Accounting for Content at Demand Media
Seeking Alpha in the Afterlife: CMG Life Services and the Life Settlement Industry
Blackstone Alternative Asset Management
Corporate Finance Project
Hubei Lantian
Converse Health System
Note on Option Valuation
